RALEIGH, N.C., Dec. 3 /PRNewswire/ -- LipoScience, Inc. is pleased to announce the election of John H. Landon to its Board of Directors.
Mr. Landon has over 30 years of broad, multi-functional experience with the DuPont Company. Prior to retiring from active management, Mr. Landon was Vice President & General Manager of Medical Products for DuPont. He had worldwide, full functional responsibility for all of DuPont’s Medical Products businesses, with total sales of $1 billion and over 5,000 employees.
Mr. Landon recently served as Chairman of the Board of Cholestech Corporation and Director of Digene Corporation. He currently is a member of the board for Christiana Care Health System and a member of the Board of Advisors for Water Street Healthcare Partners.
“John’s extensive leadership and board experience in the in vitro diagnostic industry will make a major contribution to our board,” said Dr. Charles A. Sanders, Chairman of the Board. “He will bring invaluable expertise to LipoScience as we establish the NMR LipoProfile(R) test as a clinical standard of care,” Sanders added.
About LipoScience, Inc.:
LipoScience, Inc. markets the NMR LipoProfile(R) test to clinicians, commercial diagnostic laboratories and clinical research clients. Founded in 1994, LipoScience introduced the NMR LipoProfile blood test for clinical research in 1997 and for use in patient care in 1999.
CONTACT: Tori Hall of LipoScience, Inc., +1-919-256-1046,
thall@liposcience.com
Web site: http://www.liposcience.com/
